Drawing for STANDIGM WORKFLOW AI

USPTO serial 79323022

STANDIGM WORKFLOW AI

Reviewed by CopyMark Law Group

Reg. 6914930Status 700Registered
Filing date
Status date
Registration date
Dec 6, 2022
Examiner
SCHMIDT, JOHN JOSEPH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STANDIGM WORKFLOW AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kwang Yup Chae

Kwang Yup Chae Hauptman Ham, LLPSuite 14002318 Mill Road,Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for data collection, data analysis, data storing, data mining, data generation, and machine learning in the fields of public health and healthcare; Downloadable computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bio-informatics, clinical development and statistics; Downloadable computer database software in the fields of scientific, medical, medicines, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; Pre-recorded magnetic data carriers containing information, except computer software, in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; Pre-recorded computer discs containing information in the fields of scientific, medical, clinical, pharmaceutical, biological, biotechnical, bio-informatic and statistical research; Downloadable computer software for drug development from global computer information networks; Downloadable cloud computing software; Downloadable computer software applications in the field of drug discovery and drug development; Downloadable computer software for data processing; Downloadable software for use in database management; Downloadable application software for use in database management; Downloadable computer software for digital information and data access; Downloadable computer software for data analyzing purposes in the field of medical and biotechnology using algorithm for deep learning; Downloadable computer software for simulating drug development; Downloadable software for artificial intelligence service for use in drug development; Downloadable software using artificial intelligence for drug development; Downloadable computer software for use in the field of drug discovery and drug development; Downloadable computer software for application and database integration; Downloadable computer software for analyzing medical diagnosis information; Downloadable software for the conversion, analysis, processing, storage and transmission of artificial intelligence; Downloadable software for analytics for clinical trial data for use in the field of drug discovery and drug development; Downloadable computer software for creating searchable databases of information and data for use in the field of drug discovery and drug developmentACTIVE—
042Database design and development; scientific research conducted using databases; Rental of software for data processing; Development of computer software for big data processing; Development, updating and maintenance of software and database systems; Drug discovery services; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Technical consultancy relating to medical and biotechnological data analysis and software development; Software as a service (SAAS) services featuring software for artificial intelligence based deep learning for visual and data analysis in the medical and biotechnological field; Research in the field of medical products; Consultancy in the field of testing, inspection, research of medical products; Providing information on the test, inspection and research of medical products; Medical and pharmacological research services; Scientific research and development of computer software platforms in the field of artificial intelligence; Software development for artificial intelligence service; Updating and maintenance of computer software; Rental of computer simulation programs; Drug discovery services using computer modeling technologies; Software as a service (SAAS) services featuring software for data collection, data analysis, data storing and data mining in the field of healthcare and biotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 15, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 24, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2023FIMPFINAL DISPOSITION PROCESSED—
Mar 6, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 6, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 6, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 7, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 31, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 12, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 12, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 13, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 22, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 3, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2022DOCKASSIGNED TO EXAMINER—
Feb 28, 2022CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Dec 12, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 18, 2021CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 14, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance